Product Information

ATOVAQUONE-PROGUANIL 62.5-25 is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.2264 per EA under NDC 00378416001. Its NADAC has been published 470 times since Aug 6, 2014.

The Low Outlier badge above means this manufacturer's average price in the atovaquone and proguanil hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ATOVAQUONE-PROGUANIL 62.5-25

atovaquone and proguanil hydrochloride

$1.2264per EA

Low Outlier

Strength

62.5; 25 mg/1; mg/1

Manufacturer

Mylan Pharmaceuticals Inc.

NDC

00378416001

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

ATOVAQUONE; PROGUANIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202362

On Market Since

5/28/2014

Pharmacological Classes

Antimalarial

Antiprotozoal

Dihydrofolate Reductase Inhibitors

Price Statistics

The NADAC for ATOVAQUONE-PROGUANIL 62.5-25 has been published 470 times since Aug 6, 2014, and over the history we have for it it has declined 35.0%. The table below summarizes its recorded NADAC range and movement.

Current price	$1.2264 per EA
All-time high	$1.9634 (Mar 11, 2015)
All-time low	$0.6264 (Sep 21, 2022)
52-week high	$1.3157
52-week low	$1.1576
Median price	$1.3863
Average price	$1.3951
Largest weekly change	-62.2% (Sep 21, 2022)
Weeks tracked	470
Tracking since	Aug 6, 2014

Price History

0.0%

-4.8%

-5.1%

+5.9%

-0.0%

+7.9%

-26.0%

All

-35.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the atovaquone and proguanil hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of ATOVAQUONE-PROGUANIL 62.5-25?

The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE-PROGUANIL 62.5-25, manufactured by Mylan Pharmaceuticals Inc., is $1.2264 per EA (NDC 00378416001), effective Jun 24, 2026.

How has the price of ATOVAQUONE-PROGUANIL 62.5-25 changed over time?

Over the history we have for it, the NADAC for ATOVAQUONE-PROGUANIL 62.5-25 has declined 35.0%. It has been tracked across 470 weekly CMS publications since Aug 6, 2014.

What are the highest and lowest recorded NADAC prices for ATOVAQUONE-PROGUANIL 62.5-25?

Since Aug 6, 2014, the NADAC for ATOVAQUONE-PROGUANIL 62.5-25 has ranged from a low of $0.6264 (Sep 21, 2022) to a high of $1.9634 (Mar 11, 2015), with a median of $1.3863 per EA.

Are there cheaper alternatives to ATOVAQUONE-PROGUANIL 62.5-25?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ATOVAQUONE-PROGUANIL 62.5-25, so no direct lower-cost alternative is listed.